The brain is one of the body’s most energy-demanding organs, accounting for 2 percent of the body’s weight but consuming 20 ...

First-ever clinical trial exclusively conducted among people with hard-to-treat form of tuberculosis known as pre-extensively ...

The story behind the development of immune checkpoint inhibitors, fulfilling the promise of cancer immunotherapy ...

This article is part of Harvard Medical School’s continuing coverage of medicine, biomedical research, medical education and policy related to the SARS-CoV-2 pandemic and the disease COVID-19.

The story behind the development of immune checkpoint inhibitors, fulfilling the promise of cancer… ...

A new study from investigators at the Benson-Henry Institute for Mind/Body Medicine at Massachusetts General Hospital and Beth Israel Deaconess Medical Center finds that eliciting the relaxation ...

In December 2023, through the development efforts of CRISPR Therapeutics and Vertex Pharmaceuticals, their decades-long endeavor reached fruition in the form of a new treatment, CASGEVY, approved by ...

But it’s just as important to augment disparities research with education and community-based efforts to pave the way for inclusive health care that respects and welcomes all patients, notes ...

At a glance: Study shows AI improves performance for some radiologists but worsens it for others. Understanding who might benefit from AI and who would not is critical for designing tools that boost ...

Checking Up on Symptom Checkers Web-based diagnostic and triage tools often get it wrong, but sometimes they can help guide seriously ill patients to needed care ...

Hearing loss affects about 48 million Americans and 430 million people worldwide, with those numbers expected to grow as populations age. More than 90 percent of individuals affected have ...

A team of researchers led by neuroscientists at Harvard Medical School has successfully used acupuncture to tame cytokine storms in mice with systemic inflammation. In the study, published Aug. 12 in ...